Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) modeling, physiologically based pharmacokinetic (PBPK) & physiologically based biopharmaceutics (PBBM) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better project decisions… sooner.
Upcoming Investor Presentation
4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
Most Recent Investor Presentation
BofA Securities 2021 Tech Solutions for Drug Discovery Conference
September 2021 Investor Presentation
Latest Quarterly Results
3rd Quarter Fiscal 2021 Earnings Webcast
3rd Quarter Fiscal 2021 Webcast Slides
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results